Literature DB >> 31816357

Drug delivery to macrophages: A review of targeting drugs and drug carriers to macrophages for inflammatory diseases.

Wei He1, Neha Kapate2, C Wyatt Shields3, Samir Mitragotri4.   

Abstract

Macrophages play a key role in defending against foreign pathogens, healing wounds, and regulating tissue homeostasis. Driving this versatility is their phenotypic plasticity, which enables macrophages to respond to subtle cues in tightly coordinated ways. However, when this coordination is disrupted, macrophages can aid the progression of numerous diseases, including cancer, cardiovascular disease, and autoimmune disease. The central link between these disorders is aberrant macrophage polarization, which misguides their functional programs, secretory products, and regulation of the surrounding tissue microenvironment. As a result of their important and deterministic roles in both health and disease, macrophages have gained considerable attention as targets for drug delivery. Here, we discuss the role of macrophages in the initiation and progression of various inflammatory diseases, summarize the leading drugs used to regulate macrophages, and review drug delivery systems designed to target macrophages. We emphasize strategies that are approved for clinical use or are poised for clinical investigation. Finally, we provide a prospectus of the future of macrophage-targeted drug delivery systems.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; Cardiovascular disease; Drug delivery; Inflammation; Macrophages; Solid tumors

Year:  2019        PMID: 31816357     DOI: 10.1016/j.addr.2019.12.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  26 in total

1.  Oral Administration of Cryptotanshinone-Encapsulated Nanoparticles for the Amelioration of Ulcerative Colitis.

Authors:  Li Zhang; Longfei Yu; Yueguang Wei
Journal:  Cell Mol Bioeng       Date:  2021-10-26       Impact factor: 2.321

2.  Stiripentol Enteric Solid Dispersion-Loaded Effervescent Tablets: Enhanced Dissolution, Stability, and Absorption.

Authors:  Ying Wang; Siyuan Xu; Ziyue Xiao; Yuxin Jiang; Qi Jiang; Jun Li; Wei He
Journal:  AAPS PharmSciTech       Date:  2022-05-10       Impact factor: 3.246

3.  Effect of a Novel Hybrid Nanocomposite of Cisplatin-Chitosan on Induced Tissue Injury as a Suggested Drug by Reducing Cisplatin Side Effects.

Authors:  Nagi M El-Shafai; Foad Farrag; Mustafa Shukry; Hany Mehany; Mohamed Aboelmaati; Ola Abu-Ali; Dalia Saleh; Mohamed Ramadan; Ibrahim El-Mehasseb
Journal:  Biol Trace Elem Res       Date:  2021-10-31       Impact factor: 4.081

4.  Cargo-free immunomodulatory nanoparticles combined with anti-PD-1 antibody for treating metastatic breast cancer.

Authors:  Yining Zhang; Kevin R Hughes; Ravi M Raghani; Jeffrey Ma; Sophia Orbach; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Biomaterials       Date:  2021-01-08       Impact factor: 12.479

Review 5.  Specialized pro-resolving lipid mediators in endodontics: a narrative review.

Authors:  Davy Aubeux; Ove A Peters; Sepanta Hosseinpour; Solène Tessier; Valérie Geoffroy; Fabienne Pérez; Alexis Gaudin
Journal:  BMC Oral Health       Date:  2021-05-24       Impact factor: 2.757

Review 6.  Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design.

Authors:  Qi Qiao; Xiong Liu; Ting Yang; Kexin Cui; Li Kong; Conglian Yang; Zhiping Zhang
Journal:  Acta Pharm Sin B       Date:  2021-05-07       Impact factor: 11.413

7.  Biofunctional Janus particles promote phagocytosis of tumor cells by macrophages.

Authors:  Ya-Ru Zhang; Jia-Qi Luo; Jia-Xian Li; Qiu-Yue Huang; Xiao-Xiao Shi; Yong-Cong Huang; Kam W Leong; Wei-Ling He; Jin-Zhi Du
Journal:  Chem Sci       Date:  2020-05-05       Impact factor: 9.969

8.  Thrombomodulin facilitates peripheral nerve regeneration through regulating M1/M2 switching.

Authors:  Tzu-Chieh Huang; Hua-Lin Wu; Szu-Han Chen; Yun-Ting Wang; Chia-Ching Wu
Journal:  J Neuroinflammation       Date:  2020-08-14       Impact factor: 8.322

Review 9.  Nanomedicine strategies to target coronavirus.

Authors:  Marcel Alexander Heinrich; Byron Martina; Jai Prakash
Journal:  Nano Today       Date:  2020-08-31       Impact factor: 18.962

10.  IFN- γ and TNF- α drive a CXCL10 + CCL2 + macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation.

Authors:  Fan Zhang; Joseph R Mears; Lorien Shakib; Jessica I Beynor; Sara Shanaj; Ilya Korsunsky; Aparna Nathan; Laura T Donlin; Soumya Raychaudhuri
Journal:  bioRxiv       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.